GSK shares dive as weaker sales and mounting costs unnerve investors
One day2 outlets reported this in 2 reports over 1 day
All 2 reports on Wed, 28 October 2026
What it is about
Luke MielsEmma WalmsleyBritainUnited KingdomBelgiumLondon, London, City Of, United KingdomGSKBritish pharma companyFTSE 100UK
Who published it, and when
original reportfirst to report
aol.co.uk
The Guardian World
28 Oct, 12:44over 3 hours28 Oct, 15:34
How it spread - 2 original reports
Wed, 28 October 2026
2 reports- aol.co.uk12:44first to report
British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug
- The Guardian World15:34
British pharma company one of biggest fallers on FTSE 100 despite better than expected financial results Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker sales of its respiratory syncytial virus (RSV) and shingles vaccines and recently launched medications. Britain’s second-biggest pharmaceutical company reported a 19% decline in pre-tax profit to £1.9bn in the July to...